IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Transdermals: The Skin as Part of a Drug Delivery System

Author(s):  Allen Loyd V Jr

Issue:  Jul/Aug 2011 - Volume 15, Number 4
View All Articles in Issue

Abstract:  Transdermal delivery of drugs is effective and widely used to treat many different conditions. Transdermal drug delivery can be “individualized” for each patient by changing the drugs used, their concentrations, and the formulation. This type of drug delivery is routinely used for delivery of hormones, pain medications, nonsteroidal anti-inflammatory drugs, antinauseant medications, and many, many others. This article discusses the mechanism, the factors involved, the different penetration enhancers, how to control the rate of delivery, and provides some of the advantages and disadvantages of transdermal drug delivery.

Related Keywords: Loyd V. Allen, Jr, PhD, RPh, transdermal administration, topical preparations, drug delivery, percutaneous drug absorption, formulations, scopolamine hydrobromide, promethazine, hydrogels, excipients, skin layers, anxiolytic agents, antinausea, antiemetic, nausea and vomiting, motion sickness, dexamethasone, lorazepam, haloperidol, diphenhydramine hydrochloride, metoclopramide hydrochloride, buspirone hydrochloride, hormone replacement therapy, progesterone, estradiol, testosterone, ketoprofen, piroxicam, nonsteroidal anti-inflammatory drugs, NSAIDs, amitriptyline hydrochloride, baclofen, capsaicin, ketamine, neuropathy, neuropathic pain, pain relief, analgesia, analgesic, penetration enhancers, rate controllers

Related Categories: FORMULATIONS, HRT, MENTAL HEALTH, PAIN MANAGEMENT, DOSAGE FORMS/DRUG CARRIERS, NEUROLOGY

Printer-Friendly Version




Download in electronic PDF format for $35

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Transdermals: The Skin as Part of a Drug Delivery System Allen Loyd V Jr Jul/Aug 2011 308-315 Buy
Veterinary Transdermal Medications: A to Z Davidson Gigi S Mar/Apr 2003 106-113 Buy
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr Jul/Aug 2001 310-312 Buy
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr Nov/Dec 2003 449-450 Buy
Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott May/Jun 2013 247-253 Buy
Evaluation of Percutaneous Absorption Performance for Human Female Sexual Steroids into Pentravan Cream Polonini Hudson C, Brandão Marcos Antônio F, Ferreira Anderson O, Ramos Cristiano, Raposo Nádia R B Jul/Aug 2014 332-340 Buy
Basics of Sterile Compounding: Excipients Used in Injections Akers Michael J Jul/Aug 2017 301-308 Buy
Bioavailability of Promethazine in a Topical Pluronic Lecithin Organogel: A Pilot Study Glisson James K, Wood Rebecca L, Kyle Patrick B, Cleary John D May/Jun 2005 242-246 Buy
Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery Boddu Sai HS, Bonam Sindhu Prabha, Wei Yangjie, Alexander Kenneth May/Jun 2014 256-261 Buy
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr Sep/Oct 2017 356 Buy